Open access peer-reviewed chapter

Copy Number Alterations in Glioma Cell Lines

By Bárbara Meléndez, Ainoha García-Claver, Yolanda Ruano, Yolanda Campos-Martín, Ángel Rodríguez de Lope, Elisa Pérez-Magán, Pilar Mur, Sofía Torres, Mar Lorente, Guillermo Velasco and Manuela Mollejo

Submitted: November 22nd 2010Reviewed: May 18th 2011Published: November 2nd 2011

DOI: 10.5772/22768

Downloaded: 3713

© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Bárbara Meléndez, Ainoha García-Claver, Yolanda Ruano, Yolanda Campos-Martín, Ángel Rodríguez de Lope, Elisa Pérez-Magán, Pilar Mur, Sofía Torres, Mar Lorente, Guillermo Velasco and Manuela Mollejo (November 2nd 2011). Copy Number Alterations in Glioma Cell Lines, Glioma - Exploring Its Biology and Practical Relevance, Anirban Ghosh, IntechOpen, DOI: 10.5772/22768. Available from:

chapter statistics

3713total chapter downloads

5Crossref citations

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Oxidative Stress and Glutamate Release in Glioma

By Robert Ungard and Gurmit Singh

Related Book

First chapter

Phenotypic Markers and Functional Regulators of Myelomonocytic Cells

By Luciana Cavalheiro Marti, Nydia Strachman Bacal, Laiz Camerão Bento and Fernanda Agostini Rocha

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us